Urine PD-L1 is a tumor tissue candidate substitute and is associated with poor survival in muscle-invasive bladder cancer patients

•High uPD-L1 levels are associated with severe staging.•The level of uPD-L1 is comparable to that in tissue in MIBC.•High uPD-L1 expression predicts poor prognosis in MIBC. Programmed death molecule ligand 1 (PD-L1) expression in urothelial carcinoma is a predictive marker used to guide immunotherap...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	International immunopharmacology 2023-01, Vol.114, p.109535-109535, Article 109535
Hauptverfasser:	Ma, Jialu, Zhou, Quan, Xu, Wenbin, Li, Chuangui, Wang, Haicheng, Zhai, Zhao, Zhang, Yong, Wahafu, Wasilijiang
Format:	Artikel
Sprache:	eng
Schlagworte:	B7-H1 Antigen - metabolism Biomarker Bladder urothelial carcinoma Carcinoma, Transitional Cell - drug therapy Humans Immunotherapy Muscles - chemistry Muscles - metabolism Muscles - pathology Prognosis Tissue Urinary Bladder Neoplasms - drug therapy urine PD-L1
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!